AC Immune
ACIU
19 hedge funds and large institutions have $113M invested in AC Immune in 2016 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 16 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
1.41% more ownership
Funds ownership: 14.38% → 15.79% (+1.4%)
17% less capital invested
Capital invested by funds: $136M → $113M (-$23.1M)
39% less funds holding
Funds holding: 31 → 19 (-12)
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$5.94M |
| 2 |
PC
PointState Capital
New York
|
+$4.84M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$4.13M |
| 4 |
AG
Artal Group
Luxembourg
|
+$1.38M |
| 5 |
DFO
Duquesne Family Office
New York
|
+$1.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$1.65M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$1.45M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.4M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.31M |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$988K |
ACIU Hedge Fund Activity: Q4 2016 in Review
19 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q4 2016, worth a combined $113M — down 17% from $136M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of ACIU and 5 opened new positions — a net loss of 11 holders — while 2 trimmed existing stakes and 7 added.
The largest buyer was Fidelity Investments, adding an estimated $5.94M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $1.65M sold.
- 19 institutional investors held AC Immune (ACIU) as of Q4 2016, down from 31 in Q3 2016.
- Funds reported $113M of AC Immune stock for Q4 2016, down 17% quarter-over-quarter.
- 5 funds opened new AC Immune positions in Q4 2016 and 16 closed out, a net change of -11 holders.
- The largest AC Immune buyer in Q4 2016 was Fidelity Investments, an estimated $5.94M added.
- The largest AC Immune seller in Q4 2016 was Adage Capital Partners, an estimated $1.65M sold.
Based on aggregated 13F filings for Q4 2016.